CDTTW Projected Dividend Yield
Wt Exp/Conduit Pharmaceuticals Inc ( NASDAQ : CDTTW )Conduit Pharmaceuticals, Inc. is a disease agnostic life science company. Co. is engaged in the development and commercialization of clinical assets to address the unmet medical needs of patients. Co.'s licensed clinical assets are focused on idiopathic male infertility and autoimmune diseases or immunodeficient conditions like uveitis, preterm labor, renal transplant rejection and Hashimoto's Thyroiditis. Co.'s asset pipeline includes AZD1656 (a Glucokinase Activator), and AZD5904 (a Myeloperoxidase Inhibitor). AZD1656 is a glucokinase activator used in diabetes mellitus. 21 YEAR PERFORMANCE RESULTS |
CDTTW Dividend History Detail CDTTW Dividend News CDTTW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |